Clinical Trial Update: Pediatric Long-Term Follow-up and Rollover Study [Phase 4]

View source ↗

Summary

Pediatric long-term follow-up and rollover study (Phase 4) sponsored by Novartis is active but not recruiting, tracking outcomes in children with various brain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Astrocytoma
• Diffuse Astrocytoma
• Glioblastoma
• Oligodendroglioma Childhood
• Pilocytic Astrocytoma
• Pleomorphic Xanthoastrocytoma

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING